Springtail | $2,500,000 | (Apr 10, 2025)
Ryft | $7,315,294 | (Apr 10, 2025)
Ottometric | $10,000,000 | (Apr 10, 2025)
Certified by Founder
Lodge
Broadview Ventures Inc
investor
United States
- Boston, MA
- 09/12/2022
- Series A
- $15,100,000
Broadview Ventures is a mission-driven investment organization. Its primary investment goal is to improve human health in the areas of cardiovascular disease and stroke. We define success as improving human health by bringing innovative technologies to patients.
- Industry Venture Capital and Private Equity Principals
- Website https://broadviewventures.org/
- LinkedIn https://www.linkedin.com/company/broadview-ventures-inc/
Merida Biosciences | $121,000,000 | (Apr 10, 2025)
DIAMO | $4,000,000 | (Apr 10, 2025)
Rondah AI | $1,800,000 | (Apr 10, 2025)
Pax | $4,500,000 | (Apr 10, 2025)
Luzern Risk | $12,000,000 | (Apr 10, 2025)
Adaptis | $4,000,000 | (Apr 9, 2025)
Sipay | $78,000,000 | (Apr 9, 2025)
Gallatin AI | $15,000,000 | (Apr 9, 2025)
Rain(1) | $75,000,000 | (Apr 9, 2025)